Abstract
BackgroundChronic gout is a significant clinical problem in Asia, including Japan, where many patients remain suboptimally treated with currently available therapies. Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have